Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.17%
1,102.46
+1.85
+0.17%
—1,100.611,106.151,114.281,100.55——
SIXC
Communications
SIXC
Communications
SIXC
+0.27%
613.96
+1.66
+0.27%
—612.30612.30616.23612.30——
SIXE
Energy
SIXE
Energy
SIXE
+0.83%
1,185.27
+9.81
+0.83%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.37%
1,722.78
-6.34
-0.37%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.18%
643.57
-1.16
-0.18%
—644.73645.31649.16642.92——
SIXR
Staples
SIXR
Staples
SIXR
+0.36%
830.07
+2.98
+0.36%
—827.09828.05833.90828.04——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.61%
213.51
-1.31
-0.61%
—214.82214.82216.61213.36——
SIXT
Technology
SIXT
Technology
SIXT
+1.68%
3,167.64
+52.47
+1.68%
—3,115.173,142.773,170.373,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.27%
912.90
+2.47
+0.27%
—910.43915.18923.94911.79——
SIXV
Health care
SIXV
Health care
SIXV
+0.33%
1,479.40
+4.90
+0.33%
—1,474.501,480.841,491.461,479.41——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.20%
2,401.04
-4.83
-0.20%
—2,405.872,415.572,420.792,399.55——
GS71:FRA
GSK plc
€23.99
+0.76%
(+0.18) 1D
Apr 22, 3:58:57 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GS71...
Open
€23.82
High
€24.07
Low
€23.82
Mkt. cap
113.85B
Avg. vol.
942.00
Volume
1.30K
52-wk high
€26.02
52-wk low
€15.35
No. of employees
67K
News stories
From sources across the web
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About GSK plc
CEO-
Employees66.8K
FoundedDec 27, 2000
Headquarters-
SectorPharmaceutical industry
Websitegsk.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
7.52B
7.99B
8.55B
8.62B
Cost of goods sold
1.93B
2.16B
2.24B
2.62B
Cost of revenue
1.93B
2.16B
2.24B
2.62B
Research and development expenses
1.40B
1.54B
1.58B
2.14B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.05B
2.13B
2.16B
2.67B
Operating expense
3.28B
3.43B
3.23B
4.37B
Total operating expenses
5.21B
5.59B
5.46B
6.99B
Operating income
2.31B
2.39B
3.08B
1.63B
Other non operating income
-
-
-
-21.00M
EBT including unusual items
2.11B
1.89B
2.46B
950.00M
EBT excluding unusual items
2.20B
2.26B
2.94B
1.48B
Income tax expense
336.00M
241.00M
312.00M
223.00M
Effective tax rate
15.94%
12.77%
12.70%
23.47%
Other operating expenses
-171.00M
-246.00M
-511.00M
-434.00M
Net income
1.62B
1.44B
2.01B
636.00M
Net profit margin
21.61%
18.07%
23.55%
7.38%
Earnings per share
-
0.46
0.55
-
Interest and investment income
54.00M
50.00M
26.00M
17.00M
Interest expense
-162.00M
-184.00M
-167.00M
-145.00M
Net interest expenses
-108.00M
-134.00M
-141.00M
-128.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.13B
3.55B
3.82B
2.69B
Gain or loss from assets sale
-
-
-
-40.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer